RENEW BIOLOGICS Trademark
Trademark Overview
On Sunday, September 22, 2024, a trademark application was filed for RENEW BIOLOGICS with the United States Patent and Trademark Office. The USPTO has given the RENEW BIOLOGICS trademark a serial number of 98763377. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Friday, April 4, 2025. This trademark is owned by Roger C. Sohn, MD. Inc.. The RENEW BIOLOGICS trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:
We offer regenerative treatments such as platelet rich plasma injections for musculoskeletal healing.
General Information
Serial Number | 98763377 |
Word Mark | RENEW BIOLOGICS |
Filing Date | Sunday, September 22, 2024 |
Status | 641 - NON-FINAL ACTION - MAILED |
Status Date | Friday, April 4, 2025 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
Goods and Services | We offer regenerative treatments such as platelet rich plasma injections for musculoskeletal healing. |
Classification Information
International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Sunday, September 22, 2024 |
Primary Code | 044 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | Roger C. Sohn, MD. Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 99 - Other |
Address | San Juan Capistrano, CA 92675 |
Trademark Events
Event Date | Event Description |
Sunday, September 22, 2024 | NEW APPLICATION ENTERED |
Thursday, March 27, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Friday, April 4, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Friday, April 4, 2025 | NON-FINAL ACTION E-MAILED |
Friday, April 4, 2025 | NON-FINAL ACTION WRITTEN |
Friday, March 28, 2025 | ASSIGNED TO EXAMINER |